Rac signaling in tumorigenesis and as target for anticancer drug development

Di Sun1, Duo Xu, Baolin Zhang

  • 1Department of Biomedical Engineering, Pratt School of Engineering, Duke University, Durham, NC 27708, USA.

Insights

Rac GTPases regulate cell functions and are implicated in cancer. This review covers Rac

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Biochemistry

Background:

  • Rac GTPases are key regulators of eukaryotic cell signaling, controlling functions like cytoskeleton dynamics and cell motility.
  • Their activity is tightly controlled by a GDP/GTP cycle and localization between cellular compartments.
  • Dysregulated Rac signaling is linked to human cancers, affecting tumorigenesis and metastasis.

Purpose of the Study:

  • To review recent findings on the molecular and functional roles of Rac GTPases in cancer.
  • To elucidate cellular mechanisms underlying Rac's complex role in tumorigenesis.
  • To discuss potential therapeutic strategies targeting Rac function for cancer treatment.

Main Methods:

  • Literature review of recent research on Rac GTPases in cancer.
  • Analysis of molecular mechanisms of Rac signaling in tumorigenesis and metastasis.
  • Exploration of therapeutic approaches targeting Rac pathways.

Main Results:

  • Rac GTPases mediate tumorigenic transformation and metastasis through specific molecular and functional pathways.
  • Cellular mechanisms involving Rac signaling contribute to the complex role of Rac in cancer development.
  • Modulating Rac function presents a promising avenue for novel anticancer strategies.

Conclusions:

  • Rac GTPases are critical players in cancer progression, influencing transformation and metastasis.
  • Understanding Rac's intricate cellular roles is key to developing effective cancer therapies.
  • Targeting Rac signaling pathways offers a potential strategy for future cancer treatments.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...